In this study, the anti-cancer effect of FTO is consistent with its function as an m6A demethylase—low expression of FTO enhances the m6A modification of PDK1 mRNA, thereby stabilizing PDK1 and activating the pro-cancer AKT/mTOR pathway. The gene discussed is FTO; the disease is cancer.